RecruitingNCT05376891

Met Non Small Cell Cancer Registry (MOMENT)

Disease Registry on Patients With Advanced NSCLC Harboring METex14 Skipping Alterations (MOMENT)

Sponsor

EMD Serono Research & Development Institute, Inc.

Enrollment

700 participants

Start Date

Oct 4, 2022

Study Type

OBSERVATIONAL

Conditions

Cancer

Summary

The purpose of this multi-national disease registry is to collect prospectively (with longitudinal follow-up) high-quality, standardized, and contemporaneous data to capture changes in the non-small cell lung cancer (NSCLC) treatment landscape and outcomes over time. The registry will capture data on participants; demographic, clinical characteristics (including biomarker data), treatment patterns, and effectiveness and safety outcomes for advanced NSCLC with mesenchymal-epithelial transition exon 14(METex14) participants treated with systemic therapy.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cancer. The study is currently recruiting participants at 64 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(66)

Holy Cross Health

Fort Lauderdale, Florida, United States

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Klinikum Klagenfurt Am Woerthersee

Klagenfurt, Austria

Klinik Floridsdorf

Vienna, Austria

AZ Delta

Roeselare, Belgium

AZ Nikolaas

Sint-Niklaas, Belgium

Ottawa Hospital General Campus

Ottawa, Canada

Princess Margaret Cancer Centre

Toronto, Canada

British Columbia Cancer Agency (6864)

Vancouver, Canada

FN Olomouc

Olomouc, Czechia

University Hospital Na Bulovce

Prague, Czechia

Centre Hospitalier de Cholet

Cholet, France

CHRU Lille

Lille, France

Hôpital du Scorff

Lorient, France

Centre Leon Berard

Lyon, France

Hospital Tenon & University Paris 6

Paris, France

Institut Curie - Centre de Lutte Contre le Cancer (CLCC)

Paris, France

CHU de Pontchaillou

Rennes, France

CHU de Toulouse Hopital Larrey

Toulouse, France

Klinikum Chemnitz GmbH

Chemnitz, Germany

KKH Grosshansdorf GmbH

Großhansdorf, Germany

Thoraxklinik-Heidelberg gGmbH

Heidelberg, Germany

Klinik Löwenstein GmbH

Löwenstein, Germany

Haemek Medical Center

Afula, Israel

Bnei-Zion Medical Center

Haifa, Israel

Carmel Medical Center

Haifa, Israel

Rambam Medical Center - PPDS

Haifa, Israel

Shaare Zedek Medical Center

Jerusalem, Israel

Rabin Medical Center Oncology Beilinson Campus

Petah Tikva, Israel

Chaim Sheba Medical Center

Ramat Gan, Israel

Tel Aviv Sourasky Medical Center

Tel Aviv, Israel

Istituto Europeo di Oncologia

Milan, Italy

Istituto Nazionale Dei Tumori

Milan, Italy

Azienda Ospedaliero Universitaria di Modena

Modena, Italy

Azienda Ospedaliera Dei Colli - Ospedale Monaldi

Naples, Italy

AOU dell'Università degli Studi della Campania Luigi Vanvitelli

Naples, Italy

I.F.O. Istituto Nazionale Tumori Regina Elena IRCCS

Rome, Italy

Azienda Sanitaria Ospedaliera S Luigi Gonzaga

Torino, Italy

Ospedale di Circolo

Varese, Italy

VU Medisch Centrum

Amsterdam, Netherlands

Universitair Medisch Centrum Groningen - Department of Medical Oncology

Groningen, Netherlands

Leiden University Medical Center

Leiden, Netherlands

Centro Hospitalar de Lisboa Norte, EPE - Hospital de Santa Maria

Lisbon, Portugal

Centro Hospitalar do Porto E.P.E. Hospital de Santo António

Porto, Portugal

Instituto Portugues de Oncologia Do Porto Francisco Gentil Epe - PPDS

Porto Covo, Portugal

Clinica Tres Torres

Barcelona, Spain

Institut Universitari Dexeus-Quiron - Servei d oncologia medica - Institut Oncologic Dr. Rosell

Barcelona, Spain

Complejo Hospitalario Universitario Insular-Materno Infantil

Las Palmas de Gran Canaria, Spain

Centro Integral Oncologico Clara Campa

Madrid, Spain

Centro Oncologico MD Anderson

Madrid, Spain

Hospital Regional Universitario de Malaga - Hospital General

Málaga, Spain

Hospidal Universitario Ntra. Sra. De Valme

Seville, Spain

Hospital Universitario Virgen Macarena

Seville, Spain

Hospital Universitari i Politecnic La Fe de Valencia

Valencia, Spain

Universitetssjukhuset i Linköping

Linköping, Sweden

Huddersfield Royal Infirmary

Huddersfield, West Yorkshire, United Kingdom

Bedford General Hospital

Bedford, United Kingdom

Birmingham Heartlands Hospital

Birmingham, United Kingdom

Royal Bournemouth Hospital

Bournemouth, United Kingdom

The Royal Marsden Hospital

Chelsea, United Kingdom

Northwick Park Hospital

Harrow, United Kingdom

Clatterbridge Cancer Centre - Liverpool

Liverpool, United Kingdom

Guy's Cancer Centre

London, United Kingdom

Charing Cross Hospital

London, United Kingdom

Preston Hospital

Preston, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05376891

Related Trials

Rare Tumors and Cancer Predisposition in Individuals and Families

NCT053507612 locations

Resilience Mobile App for Teens and Young Adults With Cancer

NCT058429021 location

Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer

NCT072804161 location

Impact of Gonadotoxic Therapies on Fertility

NCT058850481 location

Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data

NCT07743021